Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

Managing Amyloidosis in 2024: Diagnosis and Treatment

Indy Hematology Review

M. Gertz

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Management of AL Amyloidosis

GRACE

S. Rajeeve

Experts Discuss the Management of Monoclonal Gammopathy of Renal Sig…

MyCancerHaven

R. Vij, N. Leung

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGUS Fro…

Insights from 2023 ASH Annual Meeting

R. Banerjee

POEMS Syndrome Management

MyCancerHaven

R. Vij, D. Dingli

Updates on AL Amyloidosis Treatment: What’s New in 2024

Dana-Farber Cancer Institute

G. Bianchi

Key Myeloma & MGUS Updates From ASH

Memorial Sloan Kettering Cancer Center

S. Mailankody

Treating Amyloidosis in 2024

MyCancerHaven

R. Vij, J. Zonder

Diagnosing AL Amyloidosis

GRACE

S. Rajeeve

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Patients

Morie Gertz

Updates in the Management of SMM/MGUS and the Prevention of Progress…

Dana-Farber Cancer Institute

Y. Liu

Experts Discuss Novel Antibodies for the Management of Amyloidosis

MyCancerHaven

R. Vij, S. Lentzsch

Signs and Symptoms of AL Amyloidosis

GRACE

S. Rajeeve

Lung Involvement in Amyloidosis

Houston Methodist

H. Huang

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

University of Colorado Division of Hematology

K. Sidor

AL Amyloidosis Treatment Updates

Yale Cancer Center

T. Parker

Chapter 2: Unmet Needs in Amyloidosis Diagnosis and Care - Vaishali …

Springer Healthcare IME

V. Sanchorawala

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free Light…

Insights from 2023 ASH Annual Meeting

T. Einarsson Long